SIMG
AXDX

Sonora Investment Management Group’s Accelerate Diagnostics AXDX Stock Holding History

Sonora Investment Management Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,000
Closed -$70.6K – 287
2023
Q4 		$70.6K Buy
18,000
+7,028
+64% +$37.2K 0.01% 269
2023
Q3 		$63.1K Buy
+10,972
New +$73.8K 0.01% 256

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sonora Investment Management Group's AXDX Position: Q1 2024 in Review

Sonora Investment Management Group sold out of Accelerate Diagnostics (AXDX) in Q1 2024, closing a stake of 18,000 shares — an estimated $70.6K sold.

Sonora Investment Management Group first reported a position in AXDX in Q3 2023 and held it in 2 quarters. The position peaked at $70.6K in Q4 2023. 46 funds tracked by Wall St. Rank hold AXDX as of Q1 2024.

  • Sonora Investment Management Group reported no remaining Accelerate Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Sonora Investment Management Group sold 18,000 Accelerate Diagnostics shares in Q1 2024, an estimated $70.6K.
  • Sonora Investment Management Group first reported a position in Accelerate Diagnostics in Q3 2023 and held it in 2 quarters.
  • Sonora Investment Management Group's Accelerate Diagnostics position peaked at $70.6K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2024.

Based on Sonora Investment Management Group's 13F filing for Q1 2024, filed 14 May 2024.